|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
26
|
|
pubmed:dateCreated |
2002-12-26
|
|
pubmed:abstractText |
Current guidelines recommend that patients at risk for ulcer disease who require treatment for arthritis receive nonsteroidal antiinflammatory drugs (NSAIDs) that are selective for cyclooxygenase-2 or the combination of a nonselective NSAID with a proton-pump inhibitor. We assessed whether celecoxib would be similar to diclofenac plus omeprazole in reducing the risk of recurrent ulcer bleeding in patients at high risk for bleeding.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents...,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Ulcer Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2 Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Diclofenac,
http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Omeprazole,
http://linkedlifedata.com/resource/pubmed/chemical/PTGS2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandin-Endoperoxide Synthases,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides,
http://linkedlifedata.com/resource/pubmed/chemical/celecoxib
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:ChanFrancis K LFK,
pubmed-author:ChungS C SydneySC,
pubmed-author:HuiAric JAJ,
pubmed-author:HungLawrence C TLC,
pubmed-author:LeeKenneth CKC,
pubmed-author:LeungVincent K SVK,
pubmed-author:LeungWai KWK,
pubmed-author:SuenBing YBY,
pubmed-author:SungJoseph J YJJ,
pubmed-author:ToKa FKF,
pubmed-author:WongVincent W SVW,
pubmed-author:WuJustin C YJC
|
|
pubmed:copyrightInfo |
Copyright 2002 Massachusetts Medical Society
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
26
|
|
pubmed:volume |
347
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2104-10
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12501222-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:12501222-Anti-Ulcer Agents,
pubmed-meshheading:12501222-Arthritis,
pubmed-meshheading:12501222-Cyclooxygenase 2,
pubmed-meshheading:12501222-Cyclooxygenase 2 Inhibitors,
pubmed-meshheading:12501222-Cyclooxygenase Inhibitors,
pubmed-meshheading:12501222-Diclofenac,
pubmed-meshheading:12501222-Double-Blind Method,
pubmed-meshheading:12501222-Drug Therapy, Combination,
pubmed-meshheading:12501222-Duodenal Ulcer,
pubmed-meshheading:12501222-Helicobacter pylori,
pubmed-meshheading:12501222-Humans,
pubmed-meshheading:12501222-Isoenzymes,
pubmed-meshheading:12501222-Membrane Proteins,
pubmed-meshheading:12501222-Omeprazole,
pubmed-meshheading:12501222-Peptic Ulcer Hemorrhage,
pubmed-meshheading:12501222-Probability,
pubmed-meshheading:12501222-Prospective Studies,
pubmed-meshheading:12501222-Prostaglandin-Endoperoxide Synthases,
pubmed-meshheading:12501222-Pyrazoles,
pubmed-meshheading:12501222-Recurrence,
pubmed-meshheading:12501222-Risk Factors,
pubmed-meshheading:12501222-Stomach Ulcer,
pubmed-meshheading:12501222-Sulfonamides
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis.
|
|
pubmed:affiliation |
Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China. fklchan@cuhk.edu.hk
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
